Peter J. Weiler - 29 May 2025 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
Chief Financial Officer
Signature
/s/ Peter J. Weiler
Issuer symbol
EDSA
Transactions as of
29 May 2025
Net transactions value
$0
Form type
4
Filing time
02 Jun 2025, 21:00:08 UTC
Previous filing
02 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weiler Peter J. Chief Financial Officer C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA /s/ Peter J. Weiler 02 Jun 2025 0002066576

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award $0 +65,000 $0.000000 65,000 29 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date.